Shane O'Grady

Dec 3, 2024 | medrxiv.org | Shane O'Grady |Jessica Ralston |Fiona Lanigan |Eadaoin McKiernan

The authors have declared no competing interest. This publication has emanated from research conducted with the financial support of Precision Oncology Ireland, a Consortium of 5 Irish Universities, 6 Irish Charities, and 8 Industry Partners, which is part-funded by the Taighde Eireann:Research Ireland Strategic Partnership Programme, under Grant number [18/SPP/3522].